Correlations between therapeutic response of leukaemias and in-vitro drug-sensitivity assay
- 23 March 1991
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 337 (8743), 711-714
- https://doi.org/10.1016/0140-6736(91)90287-y
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- DRUG SENSITIVITY ASSAYS IN LEUKAEMIA AND LYMPHOMABritish Journal of Haematology, 1990
- selection of Cancer Chemotherapy for a Patient by an In Vitro Assay Versus a ClinicianJNCI Journal of the National Cancer Institute, 1990
- Current approaches to the chemotherapy of B-cell chronic lymphocytic leukemia: A reviewAmerican Journal of Hematology, 1989
- Relation of in vitro Drug Activity to Clinical Response in a Prospective Trial for Advanced Germ Cell Testicular TumorsEuropean Urology, 1989
- CARBOPLATIN OR CISPLATIN?The Lancet, 1988
- Long-term comparison of results of a drug sensitivity assayin vitro with patient response in lymphatic neoplasmsCancer, 1988
- Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in-vitro chemosensitivity of haematological malignanciesLeukemia Research, 1986
- In vitro determination of tumour chemosensitivity in haematological malignanciesHematological Oncology, 1985
- An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemiaBritish Journal of Cancer, 1983
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978